Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Screening paediatric rectal forms of azithromycin as an alternative to oral or injectable treatment.

Kauss T, Gaudin K, Gaubert A, Ba B, Tagliaferri S, Fawaz F, Fabre JL, Boiron JM, Lafarge X, White NJ, Olliaro PL, Millet P.

Int J Pharm. 2012 Oct 15;436(1-2):624-30. doi: 10.1016/j.ijpharm.2012.07.030. Epub 2012 Jul 30.

2.

Pharmaceutical development and optimization of azithromycin suppository for paediatric use.

Kauss T, Gaubert A, Boyer C, Ba BB, Manse M, Massip S, Léger JM, Fawaz F, Lembege M, Boiron JM, Lafarge X, Lindegardh N, White NJ, Olliaro P, Millet P, Gaudin K.

Int J Pharm. 2013 Jan 30;441(1-2):218-26. doi: 10.1016/j.ijpharm.2012.11.040. Epub 2012 Dec 3.

3.

Development and optimization of controlled release bioerodable anti infective ophthalmic insert.

Thakur R, Swami G, Rahman M.

Curr Drug Deliv. 2014;11(1):2-10.

PMID:
22283654
4.

Effects of food on a gastrically degraded drug: azithromycin fast-dissolving gelatin capsules and HPMC capsules.

Curatolo W, Liu P, Johnson BA, Hausberger A, Quan E, Vendola T, Vatsaraj N, Foulds G, Vincent J, Chandra R.

Pharm Res. 2011 Jul;28(7):1531-9. doi: 10.1007/s11095-011-0386-9. Epub 2011 Feb 18.

PMID:
21331473
5.

Preliminary pharmaceutical development of antimalarial-antibiotic cotherapy as a pre-referral paediatric treatment of fever in malaria endemic areas.

Gaubert A, Kauss T, Marchivie M, Ba BB, Lembege M, Fawaz F, Boiron JM, Lafarge X, Lindegardh N, Fabre JL, White NJ, Olliaro PL, Millet P, Grislain L, Gaudin K.

Int J Pharm. 2014 Jul 1;468(1-2):55-63. doi: 10.1016/j.ijpharm.2014.04.023. Epub 2014 Apr 13.

6.

Amorphous azithromycin with improved aqueous solubility and intestinal membrane permeability.

Aucamp M, Odendaal R, Liebenberg W, Hamman J.

Drug Dev Ind Pharm. 2015;41(7):1100-8. doi: 10.3109/03639045.2014.931967. Epub 2014 Jul 1.

PMID:
24980913
7.

Bioavailability and in vitro oesophageal sticking tendency of hydroxypropyl methylcellulose capsule formulations and corresponding gelatine capsule formulations.

Honkanen O, Laaksonen P, Marvola J, Eerikäinen S, Tuominen R, Marvola M.

Eur J Pharm Sci. 2002 Jun;15(5):479-88. Erratum in: Eur J Pharm Sci 2002 Oct;17(1-2):105. Pia, Laaksonen [corrected to Laaksonen, Pia]; Janne, Marvola [corrected to Marvola, Janne]; Raimo, Tuominen [corrected to Tuominen, Raimo]; Sari, Eerikäinen [corrected to Eerikäinen, Sari]; Martti, Marvola [corrected to Marvola, Martti].

PMID:
12036724
8.

The in vitro dissolution of theophylline from different types of hard shell capsules.

Podczeck F, Jones BE.

Drug Dev Ind Pharm. 2002 Oct;28(9):1163-9.

PMID:
12455475
10.

Study on rectal administration of azithromycin by suppository for pediatric use.

Maeda M, Nakano Y, Aoyama T, Matsumoto Y, Fujito H.

Int J Clin Pharmacol Ther. 2016 Apr;54(4):263-8. doi: 10.5414/CP202423.

PMID:
26833461
11.

A comparison of in vitro ADME properties and pharmacokinetics of azithromycin and selected 15-membered ring macrolides in rodents.

Milić A, Mihaljević VB, Ralić J, Bokulić A, Nožinić D, Tavčar B, Mildner B, Munić V, Malnar I, Padovan J.

Eur J Drug Metab Pharmacokinet. 2014 Dec;39(4):263-76. doi: 10.1007/s13318-013-0155-8. Epub 2013 Oct 10.

PMID:
24114177
13.

Interdisciplinary science and the design of a single-dose antibiotic therapy.

Curatolo W.

Pharm Res. 2011 Sep;28(9):2059-71. doi: 10.1007/s11095-011-0382-0. Epub 2011 Feb 11. Review.

PMID:
21311957
14.
15.

Stabilization of hard gelatin capsule shells filled with polyethylene glycol matrices.

Stein D, Bindra DS.

Pharm Dev Technol. 2007;12(1):71-7.

PMID:
17484146
16.

Accelerated oral absorption of gliclazide in human subjects from a soft gelatin capsule containing a PEG 400 suspension of gliclazide.

Hong SS, Lee SH, Lee YJ, Chung SJ, Lee MH, Shim CK.

J Control Release. 1998 Feb 12;51(2-3):185-92.

PMID:
9685916
17.

High azithromycin loading powders for inhalation and their in vivo evaluation in rats.

Zhang Y, Wang X, Lin X, Liu X, Tian B, Tang X.

Int J Pharm. 2010 Aug 16;395(1-2):205-14. doi: 10.1016/j.ijpharm.2010.05.043. Epub 2010 Jun 4.

PMID:
20595022
18.
19.

Comparative pharmacokinetic and relative bioavailability study of coated and uncoated azithromycin powder for suspension in healthy Bangladeshi male volunteers.

Sultana TA, Islam MS, Bhuiyan NH, Shohag MH, Ahmed MU, Naznin SR, Al Maruf A, Huq SM, Hasnat A.

Arzneimittelforschung. 2011;61(10):594-8. doi: 10.1055/s-0031-1300558.

PMID:
22164968
20.

Bioavailability enhancement of a poorly water-soluble drug by solid dispersion in polyethylene glycol-polysorbate 80 mixture.

Joshi HN, Tejwani RW, Davidovich M, Sahasrabudhe VP, Jemal M, Bathala MS, Varia SA, Serajuddin AT.

Int J Pharm. 2004 Jan 9;269(1):251-8.

PMID:
14698596
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk